10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GIKLY (Grifols) Stock Analysis
Buy, Hold or Sell?

Let's analyze Grifols together

I guess you are interested in Grifols SA ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Grifols’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Grifols’s Price Targets

I'm going to help you getting a better view of Grifols SA ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Grifols SA ADR

I send you an email if I find something interesting about Grifols SA ADR.

1. Quick Overview

1.1. Quick analysis of Grifols (30 sec.)










1.2. What can you expect buying and holding a share of Grifols? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
$3.71
Expected worth in 1 year
$4.79
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
$1.08
Return On Investment
16.1%

For what price can you sell your share?

Current Price per Share
$6.70
Expected price per share
$6.14 - $6.14
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Grifols (5 min.)




Live pricePrice per Share (EOD)
$6.70
Intrinsic Value Per Share
$-0.60 - $2.11
Total Value Per Share
$3.11 - $5.82

2.2. Growth of Grifols (5 min.)




Is Grifols growing?

Current yearPrevious yearGrowGrow %
How rich?$10b$9.3b$744m7.4%

How much money is Grifols making?

Current yearPrevious yearGrowGrow %
Making money$184m$69.5m$114.4m62.2%
Net Profit Margin2.2%0.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Grifols (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Grifols?

Welcome investor! Grifols's management wants to use your money to grow the business. In return you get a share of Grifols.

First you should know what it really means to hold a share of Grifols. And how you can make/lose money.

Speculation

The Price per Share of Grifols is $6.7. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Grifols.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Grifols, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.71. Based on the TTM, the Book Value Change Per Share is $0.27 per quarter. Based on the YOY, the Book Value Change Per Share is $-3.87 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Grifols.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.071.0%0.071.0%0.030.4%0.091.4%0.192.9%0.253.7%
Usd Book Value Change Per Share0.274.0%0.274.0%-3.87-57.8%-1.11-16.6%-0.43-6.4%0.263.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.061.0%0.091.4%
Usd Total Gains Per Share0.274.0%0.274.0%-3.87-57.8%-1.11-16.6%-0.37-5.5%0.355.2%
Usd Price Per Share4.70-4.70-8.54-6.33-8.64-11.20-
Price to Earnings Ratio69.52-69.52-333.70-145.05-104.69-76.22-
Price-to-Total Gains Ratio17.38-17.38--2.21-12.15--496.34--234.94-
Price to Book Ratio1.27-1.27-2.48-1.51-1.69-4.39-
Price-to-Total Gains Ratio17.38-17.38--2.21-12.15--496.34--234.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.7
Number of shares149
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.06
Usd Book Value Change Per Share0.27-0.43
Usd Total Gains Per Share0.27-0.37
Gains per Quarter (149 shares)40.30-54.49
Gains per Year (149 shares)161.22-217.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1016115138-256-228
2032231277-513-446
31483473115-769-664
41644634153-1025-882
51805795192-1281-1100
61966956230-1538-1318
7211271117268-1794-1536
8212881278307-2050-1754
9214491439345-2307-1972
10216101600383-2563-2190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%15.05.00.075.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%18.00.02.090.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%16.04.00.080.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Grifols SA ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2700.2700%-3.871+1533%-1.110+511%-0.430+259%0.257+5%
Book Value Per Share--3.7083.7080%3.438+8%4.819-23%5.450-32%3.969-7%
Current Ratio--2.6562.6560%2.774-4%2.603+2%2.353+13%2.732-3%
Debt To Asset Ratio--0.5980.5980%0.628-5%0.611-2%0.594+1%0.611-2%
Debt To Equity Ratio--2.1752.1750%2.311-6%2.207-1%2.023+8%1.940+12%
Dividend Per Share--0.0000.0000%-+100%0.000+34%0.064-99%0.093-100%
Enterprise Value---1041772403.000-1041772403.0000%8173526164.936-113%96421034.657-1180%2824031743.297-137%16635938344.494-106%
Eps--0.0680.0680%0.026+164%0.091-26%0.192-65%0.250-73%
Ev To Ebitda Ratio---0.598-0.5980%5.897-110%0.164-466%2.086-129%11.606-105%
Ev To Sales Ratio---0.123-0.1230%1.057-112%-0.009-92%0.444-128%3.267-104%
Free Cash Flow Per Share--0.2290.2290%-0.038+116%-0.048+121%0.148+54%0.147+56%
Free Cash Flow To Equity Per Share---0.357-0.3570%0.043-936%-0.266-25%0.211-269%0.197-281%
Gross Profit Margin--1.0001.0000%-0.806+181%-0.670+167%-0.473+147%0.264+279%
Intrinsic Value_10Y_max--2.113----------
Intrinsic Value_10Y_min---0.599----------
Intrinsic Value_1Y_max--0.162----------
Intrinsic Value_1Y_min---0.051----------
Intrinsic Value_3Y_max--0.525----------
Intrinsic Value_3Y_min---0.163----------
Intrinsic Value_5Y_max--0.934----------
Intrinsic Value_5Y_min---0.282----------
Market Cap5657285753.600-126%12791691155.20012791691155.2000%23209598902.336-45%14599647524.791-12%15364218814.137-17%24119023428.564-47%
Net Profit Margin--0.0220.0220%0.009+142%0.022+0%0.047-54%0.091-76%
Operating Margin--0.1450.1450%0.112+30%0.130+12%0.137+6%0.185-22%
Operating Ratio--0.8350.8350%0.879-5%0.866-4%0.860-3%0.815+2%
Pb Ratio1.807+30%1.2671.2670%2.483-49%1.512-16%1.688-25%4.395-71%
Pe Ratio99.101+30%69.51869.5180%333.698-79%145.048-52%104.693-34%76.221-9%
Price Per Share6.700+30%4.7004.7000%8.536-45%6.328-26%8.637-46%11.204-58%
Price To Free Cash Flow Ratio29.297+30%20.55220.5520%-227.151+1205%-74.603+463%-32.321+257%41.877-51%
Price To Total Gains Ratio24.769+30%17.37517.3750%-2.205+113%12.146+43%-496.337+2957%-234.942+1452%
Quick Ratio--0.9750.9750%0.676+44%0.768+27%0.905+8%1.275-24%
Return On Assets--0.0070.0070%0.003+165%0.007+11%0.015-51%0.033-78%
Return On Equity--0.0270.0270%0.010+162%0.024+13%0.047-43%0.100-73%
Total Gains Per Share--0.2710.2710%-3.871+1531%-1.110+510%-0.366+235%0.350-23%
Usd Book Value--10092597515.00010092597515.0000%9348535911.000+8%9786149840.133+3%9358319850.880+8%7283000893.740+39%
Usd Book Value Change Per Share--0.2700.2700%-3.871+1533%-1.110+511%-0.430+259%0.257+5%
Usd Book Value Per Share--3.7083.7080%3.438+8%4.819-23%5.450-32%3.969-7%
Usd Dividend Per Share--0.0000.0000%-+100%0.000+34%0.064-99%0.093-100%
Usd Enterprise Value---1041772403.000-1041772403.0000%8173526164.936-113%96421034.657-1180%2824031743.297-137%16635938344.494-106%
Usd Eps--0.0680.0680%0.026+164%0.091-26%0.192-65%0.250-73%
Usd Free Cash Flow--622417252.600622417252.6000%-102176846.200+116%22372035.400+2682%254899788.000+144%308200672.780+102%
Usd Free Cash Flow Per Share--0.2290.2290%-0.038+116%-0.048+121%0.148+54%0.147+56%
Usd Free Cash Flow To Equity Per Share---0.357-0.3570%0.043-936%-0.266-25%0.211-269%0.197-281%
Usd Market Cap5657285753.600-126%12791691155.20012791691155.2000%23209598902.336-45%14599647524.791-12%15364218814.137-17%24119023428.564-47%
Usd Price Per Share6.700+30%4.7004.7000%8.536-45%6.328-26%8.637-46%11.204-58%
Usd Profit--184004392.000184004392.0000%69552769.000+165%165928372.133+11%306842919.240-40%500756015.760-63%
Usd Revenue--8457239133.2008457239133.2000%7729752230.200+9%7765866355.867+9%7068780358.640+20%6100963105.380+39%
Usd Total Gains Per Share--0.2710.2710%-3.871+1531%-1.110+510%-0.366+235%0.350-23%
 EOD+2 -6MRQTTM+0 -0YOY+29 -113Y+26 -145Y+18 -2210Y+14 -26

3.3 Fundamental Score

Let's check the fundamental score of Grifols SA ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1599.101
Price to Book Ratio (EOD)Between0-11.807
Net Profit Margin (MRQ)Greater than00.022
Operating Margin (MRQ)Greater than00.145
Quick Ratio (MRQ)Greater than10.975
Current Ratio (MRQ)Greater than12.656
Debt to Asset Ratio (MRQ)Less than10.598
Debt to Equity Ratio (MRQ)Less than12.175
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.007
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Grifols SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose6.640
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Grifols SA ADR

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factor VIII/von Willebrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It also markets diagnostic testing equipment, reagents, and other equipment; offers biological products and manufacturing services; and manufactures and sells plasma to third parties. In addition, the company offers Yimmugo IDP, an immunology drug; Yimmugo PTI, a hematology drug; and Prolastin vials, a pulmonology drug. Further, it develops Xembify Pre-filled syringes, Gamunex Bags, and FlexBag; Xembify Biweekly dosing, Fibrinogen, and VISTASEAL; Prolastin-C AADT and Fostamatinib; Xembify " CLL, Albumina 20% and 5%, and Trimodulin; Alfa-1 AT 15%, GRF6019, GRF6021, Aßvac402, AKST4290, and AKST4290; GIGA 2339 and GIGA564; and recIG, Alfa-1 AT - in non-cystic fibrosis bronchiectasis, and OSIG that are in pre-clinical stage. It has collaboration agreements with Canadian Blood Services to supply grains of Immunoglobulin. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Fundamental data was last updated by Penke on 2025-06-29 14:42:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Grifols earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 2.2%Β means thatΒ $0.02 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Grifols SA ADR:

  • The MRQ is 2.2%. The company is making a profit. +1
  • The TTM is 2.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.2%TTM2.2%0.0%
TTM2.2%YOY0.9%+1.3%
TTM2.2%5Y4.7%-2.5%
5Y4.7%10Y9.1%-4.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Grifols is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 0.7% Return on Assets means thatΒ Grifols generatedΒ $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Grifols SA ADR:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.7%0.0%
TTM0.7%YOY0.3%+0.5%
TTM0.7%5Y1.5%-0.7%
5Y1.5%10Y3.3%-1.8%
4.3.1.3. Return on Equity

Shows how efficient Grifols is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 2.7% Return on Equity means Grifols generated $0.03Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Grifols SA ADR:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.7%0.0%
TTM2.7%YOY1.0%+1.6%
TTM2.7%5Y4.7%-2.0%
5Y4.7%10Y10.0%-5.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Grifols SA ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Grifols is operatingΒ .

  • Measures how much profit Grifols makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • An Operating Margin of 14.5%Β means the company generated $0.15 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Grifols SA ADR:

  • The MRQ is 14.5%. The company is operating less efficient.
  • The TTM is 14.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ14.5%TTM14.5%0.0%
TTM14.5%YOY11.2%+3.4%
TTM14.5%5Y13.7%+0.8%
5Y13.7%10Y18.5%-4.8%
4.3.2.2. Operating Ratio

Measures how efficient Grifols is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.83 means that the operating costs are $0.83 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Grifols SA ADR:

  • The MRQ is 0.835. The company is less efficient in keeping operating costs low.
  • The TTM is 0.835. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.835TTM0.8350.000
TTM0.835YOY0.879-0.044
TTM0.8355Y0.860-0.025
5Y0.86010Y0.815+0.045
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Grifols SA ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Grifols is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.66Β means the company has $2.66 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Grifols SA ADR:

  • The MRQ is 2.656. The company is able to pay all its short-term debts. +1
  • The TTM is 2.656. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.656TTM2.6560.000
TTM2.656YOY2.774-0.118
TTM2.6565Y2.353+0.303
5Y2.35310Y2.732-0.379
4.4.3.2. Quick Ratio

Measures if Grifols is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.97Β means the company can pay off $0.97 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Grifols SA ADR:

  • The MRQ is 0.975. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.975. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.975TTM0.9750.000
TTM0.975YOY0.676+0.298
TTM0.9755Y0.905+0.070
5Y0.90510Y1.275-0.371
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Grifols SA ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of GrifolsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Grifols to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.60Β means that Grifols assets areΒ financed with 59.8% credit (debt) and the remaining percentage (100% - 59.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Grifols SA ADR:

  • The MRQ is 0.598. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.598. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.5980.000
TTM0.598YOY0.628-0.030
TTM0.5985Y0.594+0.004
5Y0.59410Y0.611-0.017
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Grifols is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 217.5% means that company has $2.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Grifols SA ADR:

  • The MRQ is 2.175. The company is just not able to pay all its debts with equity.
  • The TTM is 2.175. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.175TTM2.1750.000
TTM2.175YOY2.311-0.136
TTM2.1755Y2.023+0.153
5Y2.02310Y1.940+0.083
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Grifols generates.

  • Above 15 is considered overpriced butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A PE ratio of 69.52 means the investor is paying $69.52Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Grifols SA ADR:

  • The EOD is 99.101. Based on the earnings, the company is expensive. -2
  • The MRQ is 69.518. Based on the earnings, the company is expensive. -2
  • The TTM is 69.518. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD99.101MRQ69.518+29.582
MRQ69.518TTM69.5180.000
TTM69.518YOY333.698-264.179
TTM69.5185Y104.693-35.175
5Y104.69310Y76.221+28.473
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Grifols SA ADR:

  • The EOD is 29.297. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.552. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.552. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD29.297MRQ20.552+8.745
MRQ20.552TTM20.5520.000
TTM20.552YOY-227.151+247.703
TTM20.5525Y-32.321+52.873
5Y-32.32110Y41.877-74.198
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Grifols is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.27 means the investor is paying $1.27Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Grifols SA ADR:

  • The EOD is 1.807. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.267. Based on the equity, the company is underpriced. +1
  • The TTM is 1.267. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.807MRQ1.267+0.539
MRQ1.267TTM1.2670.000
TTM1.267YOY2.483-1.215
TTM1.2675Y1.688-0.420
5Y1.68810Y4.395-2.707
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets21,405,241
Total Liabilities12,798,216
Total Stockholder Equity5,883,727
 As reported
Total Liabilities 12,798,216
Total Stockholder Equity+ 5,883,727
Total Assets = 21,405,241

Assets

Total Assets21,405,241
Total Current Assets5,727,542
Long-term Assets15,677,699
Total Current Assets
Cash And Cash Equivalents 979,780
Short-term Investments 21,179
Net Receivables 1,079,316
Inventory 3,560,098
Other Current Assets 87,169
Total Current Assets  (as reported)5,727,542
Total Current Assets  (calculated)5,727,542
+/-0
Long-term Assets
Property Plant Equipment 4,310,150
Goodwill 7,403,056
Long Term Investments 528,972
Intangible Assets 2,926,132
Long-term Assets Other 167,716
Long-term Assets  (as reported)15,677,699
Long-term Assets  (calculated)15,336,026
+/- 341,673

Liabilities & Shareholders' Equity

Total Current Liabilities2,156,146
Long-term Liabilities10,642,070
Total Stockholder Equity5,883,727
Total Current Liabilities
Short-term Debt 639,661
Short Long Term Debt 523,127
Accounts payable 852,305
Other Current Liabilities 508,329
Total Current Liabilities  (as reported)2,156,146
Total Current Liabilities  (calculated)2,523,422
+/- 367,276
Long-term Liabilities
Long term Debt 8,421,113
Capital Lease Obligations 1,141,379
Long-term Liabilities Other 45,416
Long-term Liabilities  (as reported)10,642,070
Long-term Liabilities  (calculated)9,607,908
+/- 1,034,162
Total Stockholder Equity
Common Stock119,604
Retained Earnings 156,920
Accumulated Other Comprehensive Income 4,830,923
Other Stockholders Equity 776,280
Total Stockholder Equity (as reported)5,883,727
Total Stockholder Equity (calculated)5,883,727
+/-0
Other
Capital Stock119,604
Cash and Short Term Investments 1,000,959
Common Stock Shares Outstanding 2,721,636
Current Deferred Revenue70,865
Liabilities and Stockholders Equity 21,405,241
Net Debt 9,105,839
Net Invested Capital 14,827,967
Net Working Capital 3,571,396
Property Plant and Equipment Gross 6,950,825
Short Long Term Debt Total 10,085,619



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
821,683
913,674
939,569
1,180,239
1,657,177
1,888,982
5,807,718
5,627,474
5,841,036
8,449,749
9,601,715
10,129,772
10,920,264
12,477,046
15,542,611
15,274,776
19,233,835
21,533,977
21,441,054
21,405,241
21,405,24121,441,05421,533,97719,233,83515,274,77615,542,61112,477,04610,920,26410,129,7729,601,7158,449,7495,841,0365,627,4745,807,7181,888,9821,657,1771,180,239939,569913,674821,683
   > Total Current Assets 
436,294
473,294
495,527
626,600
1,004,578
1,144,082
1,929,215
1,934,564
2,139,660
2,913,122
3,089,472
3,122,514
2,945,316
3,483,251
5,362,184
3,164,954
5,510,280
4,653,587
6,451,905
5,727,542
5,727,5426,451,9054,653,5875,510,2803,164,9545,362,1843,483,2512,945,3163,122,5143,089,4722,913,1222,139,6601,934,5641,929,2151,144,0821,004,578626,600495,527473,294436,294
       Cash And Cash Equivalents 
22,856
26,883
5,690
6,368
249,372
239,649
340,586
473,327
708,777
1,079,146
1,142,500
895,009
886,521
1,033,792
741,982
579,647
655,493
547,979
529,577
979,780
979,780529,577547,979655,493579,647741,9821,033,792886,521895,0091,142,5001,079,146708,777473,327340,586239,649249,3726,3685,69026,88322,856
       Short-term Investments 
661
6,232
7,080
6,657
8,217
12,946
16,904
192
232
476
509
957
702
822
1,727,429
10,861
2,029,107
43,256
116,143
21,179
21,179116,14343,2562,029,10710,8611,727,42982270295750947623219216,90412,9468,2176,6577,0806,232661
       Net Receivables 
147,710
188,868
200,472
231,806
255,182
282,994
108,616
366,048
385,564
500,785
362,406
413,656
286,198
269,167
369,797
383,233
434,136
643,842
810,980
1,079,316
1,079,316810,980643,842434,136383,233369,797269,167286,198413,656362,406500,785385,564366,048108,616282,994255,182231,806200,472188,868147,710
       Inventory 
249,545
235,475
270,659
373,098
484,462
527,865
1,030,341
998,644
946,913
1,194,057
1,431,391
1,642,931
1,629,293
1,949,360
2,342,590
2,002,281
2,259,354
3,201,357
3,459,277
3,560,098
3,560,0983,459,2773,201,3572,259,3542,002,2812,342,5901,949,3601,629,2931,642,9311,431,3911,194,057946,913998,6441,030,341527,865484,462373,098270,659235,475249,545
       Other Current Assets 
15,522
15,836
11,626
8,671
7,345
80,628
19,085
96,545
98,406
139,134
153,175
170,918
44,237
230,932
1,907,815
199,793
131,629
229,423
1,535,928
87,169
87,1691,535,928229,423131,629199,7931,907,815230,93244,237170,918153,175139,13498,40696,54519,08580,6287,3458,67111,62615,83615,522
   > Long-term Assets 
385,389
440,380
444,042
553,639
652,599
744,900
3,878,503
3,692,910
3,701,376
5,536,627
6,512,243
7,007,258
7,974,948
8,993,795
10,180,427
12,109,822
13,723,555
16,880,390
14,989,149
15,677,699
15,677,69914,989,14916,880,39013,723,55512,109,82210,180,4278,993,7957,974,9487,007,2586,512,2435,536,6273,701,3763,692,9103,878,503744,900652,599553,639444,042440,380385,389
       Property Plant Equipment 
186,621
184,993
201,332
301,009
371,705
434,131
775,869
810,107
840,238
1,147,782
1,644,402
1,809,852
1,760,053
1,951,983
2,863,403
3,002,803
3,343,154
4,168,489
4,192,363
4,310,150
4,310,1504,192,3634,168,4893,343,1543,002,8032,863,4031,951,9831,760,0531,809,8521,644,4021,147,782840,238810,107775,869434,131371,705301,009201,332184,993186,621
       Goodwill 
117,115
150,820
150,243
158,567
174,000
189,448
1,895,101
1,869,899
1,829,141
3,174,732
3,532,359
3,643,995
4,590,498
5,209,230
5,507,063
5,332,271
6,228,901
7,011,909
6,802,127
7,403,056
7,403,0566,802,1277,011,9096,228,9015,332,2715,507,0635,209,2304,590,4983,643,9953,532,3593,174,7321,829,1411,869,8991,895,101189,448174,000158,567150,243150,820117,115
       Long Term Investments 
0
0
0
0
0
0
0
0
39,130
44,242
78,137
232,421
259,063
228,820
143,984
2,067,177
2,359,975
2,548,892
565,105
528,972
528,972565,1052,548,8922,359,9752,067,177143,984228,820259,063232,42178,13744,24239,13000000000
       Intangible Assets 
48,718
60,850
57,223
57,756
69,385
78,299
1,008,307
969,095
946,435
1,068,361
1,161,572
1,195,302
1,269,342
1,385,537
1,433,534
1,557,650
1,636,950
2,949,147
1,207,545
2,926,132
2,926,1321,207,5452,949,1471,636,9501,557,6501,433,5341,385,5371,269,3421,195,3021,161,5721,068,361946,435969,0951,008,30778,29969,38557,75657,22360,85048,718
       Other Assets 
0
0
0
0
0
0
0
0
46,432
99,844
140,910
156,107
328,337
505,430
564,251
812,555
882,614
1,930,408
-13,616
0
0-13,6161,930,408882,614812,555564,251505,430328,337156,107140,91099,84446,43200000000
> Total Liabilities 
765,736
545,322
555,403
698,960
1,078,649
1,181,592
4,142,724
3,746,733
3,733,832
5,786,861
6,300,325
6,401,794
7,286,299
7,780,442
8,696,843
8,554,721
11,086,800
13,076,433
13,468,569
12,798,216
12,798,21613,468,56913,076,43311,086,8008,554,7218,696,8437,780,4427,286,2996,401,7946,300,3255,786,8613,733,8323,746,7334,142,7241,181,5921,078,649698,960555,403545,322765,736
   > Total Current Liabilities 
252,405
282,764
316,576
317,538
299,043
423,126
646,077
592,865
715,296
1,079,711
1,053,006
1,071,763
977,987
1,257,321
1,366,558
1,335,138
3,474,312
1,955,847
2,325,443
2,156,146
2,156,1462,325,4431,955,8473,474,3121,335,1381,366,5581,257,321977,9871,071,7631,053,0061,079,711715,296592,865646,077423,126299,043317,538316,576282,764252,405
       Short-term Debt 
103,635
138,881
183,992
151,710
113,991
194,915
150,224
192,003
251,410
164,389
193,729
203,944
133,067
261,120
319,544
321,359
2,398,341
794,953
1,013,481
639,661
639,6611,013,481794,9532,398,341321,359319,544261,120133,067203,944193,729164,389251,410192,003150,224194,915113,991151,710183,992138,881103,635
       Short Long Term Debt 
0
0
0
0
0
0
0
0
2,730,711
116,593
188,073
200,085
129,122
264,851
276,397
276,929
2,345,615
578,917
790,814
523,127
523,127790,814578,9172,345,615276,929276,397264,851129,122200,085188,073116,5932,730,71100000000
       Accounts payable 
70,587
81,513
76,934
99,215
120,909
160,678
280,722
228,405
273,621
439,631
409,986
461,073
423,096
561,883
581,882
601,618
628,992
731,918
813,114
852,305
852,305813,114731,918628,992601,618581,882561,883423,096461,073409,986439,631273,621228,405280,722160,678120,90999,21576,93481,51370,587
       Other Current Liabilities 
78,183
62,370
51,880
50,251
60,885
63,361
210,440
157,462
174,661
361,446
402,822
358,037
382,204
397,148
422,328
390,156
422,185
394,170
445,132
508,329
508,329445,132394,170422,185390,156422,328397,148382,204358,037402,822361,446174,661157,462210,44063,36160,88550,25151,88062,37078,183
   > Long-term Liabilities 
513,331
262,558
238,827
381,422
779,606
758,466
3,496,647
3,153,868
3,018,536
4,707,150
5,247,319
5,330,031
6,308,312
6,523,121
7,330,285
7,219,583
7,612,488
11,120,586
11,152,965
10,642,070
10,642,07011,152,96511,120,5867,612,4887,219,5837,330,2856,523,1216,308,3125,330,0315,247,3194,707,1503,018,5363,153,8683,496,647758,466779,606381,422238,827262,558513,331
       Other Liabilities 
0
0
0
0
0
0
0
0
536,531
453,414
675,473
648,935
430,134
502,613
544,198
627,755
682,364
2,051,734
0
0
002,051,734682,364627,755544,198502,613430,134648,935675,473453,414536,53100000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
34,142
45,137
70,620
232,345
287,205
331,808
575,515
633,240
1,622,641
0
0
001,622,641633,240575,515331,808287,205232,34570,62045,13734,142000000000
> Total Stockholder Equity
55,826
367,944
383,185
480,029
566,371
693,040
1,662,507
1,876,768
2,101,262
2,658,123
3,296,203
3,721,481
3,629,079
4,225,554
4,822,119
5,108,392
6,096,643
6,129,938
5,827,166
5,883,727
5,883,7275,827,1666,129,9386,096,6435,108,3924,822,1194,225,5543,629,0793,721,4813,296,2032,658,1232,101,2621,876,7681,662,507693,040566,371480,029383,185367,94455,826
   Common Stock
70,169
106,532
106,532
106,532
0
0
117,882
1,008,237
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
119,604
119,604
119,604119,6041,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,008,237117,88200106,532106,532106,53270,169
   Retained Earnings 
25,556
45,394
0
0
147,972
115,513
50,307
256,686
276,796
384,309
412,530
422,548
539,714
459,895
488,318
618,546
182,803
208,279
42,318
156,920
156,92042,318208,279182,803618,546488,318459,895539,714422,548412,530384,309276,796256,68650,307115,513147,9720045,39425,556
   Accumulated Other Comprehensive Income 
-39,899
216,018
85,940
163,054
224,650
352,871
627,074
614,905
794,134
1,312,734
1,911,916
2,337,311
2,121,455
2,790,768
3,353,053
3,503,248
5,047,697
5,053,547
4,448,474
4,830,923
4,830,9234,448,4745,053,5475,047,6973,503,2483,353,0532,790,7682,121,4552,337,3111,911,9161,312,734794,134614,905627,074352,871224,650163,05485,940216,018-39,899
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,212,382
Cost of Revenue-4,417,844
Gross Profit2,794,5382,794,538
 
Operating Income (+$)
Gross Profit2,794,538
Operating Expense-1,602,523
Operating Income1,192,0151,192,015
 
Operating Expense (+$)
Research Development384,036
Selling General Administrative1,255,291
Selling And Marketing Expenses-
Operating Expense1,602,5231,639,327
 
Net Interest Income (+$)
Interest Income44,423
Interest Expense-602,571
Other Finance Cost-142,976
Net Interest Income-701,124
 
Pretax Income (+$)
Operating Income1,192,015
Net Interest Income-701,124
Other Non-Operating Income Expenses-
Income Before Tax (EBT)443,9961,940,034
EBIT - interestExpense = 443,996
388,110
759,491
Interest Expense602,571
Earnings Before Interest and Taxes (EBIT)1,046,5671,046,567
Earnings Before Interest and Taxes (EBITDA)1,484,464
 
After tax Income (+$)
Income Before Tax443,996
Tax Provision-231,190
Net Income From Continuing Ops212,806212,806
Net Income156,920
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses6,020,367
Total Other Income/Expenses Net-748,019701,124
 

Technical Analysis of Grifols
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Grifols. The general trend of Grifols is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Grifols's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Grifols Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Grifols SA ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 6.14 < 6.14 < 6.14.

The bearish price targets are: 6.14 > 6.14 > 6.14.

Know someone who trades $GIKLY? Share this with them.πŸ‘‡

Grifols SA ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Grifols SA ADR. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Grifols SA ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Grifols SA ADR.

Grifols SA ADR Daily Moving Average Convergence/Divergence (MACD) ChartGrifols SA ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Grifols SA ADR. The current adx is .

Grifols SA ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Grifols SA ADR.

Grifols SA ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Grifols SA ADR.

Grifols SA ADR Daily Relative Strength Index (RSI) ChartGrifols SA ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Grifols SA ADR.

Grifols SA ADR Daily Stochastic Oscillator ChartGrifols SA ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Grifols SA ADR.

Grifols SA ADR Daily Commodity Channel Index (CCI) ChartGrifols SA ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Grifols SA ADR.

Grifols SA ADR Daily Chande Momentum Oscillator (CMO) ChartGrifols SA ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Grifols SA ADR.

Grifols SA ADR Daily Williams %R ChartGrifols SA ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Grifols SA ADR.

Grifols SA ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Grifols SA ADR.

Grifols SA ADR Daily Average True Range (ATR) ChartGrifols SA ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Grifols SA ADR.

Grifols SA ADR Daily On-Balance Volume (OBV) ChartGrifols SA ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Grifols SA ADR.

Grifols SA ADR Daily Money Flow Index (MFI) ChartGrifols SA ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Grifols SA ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Grifols SA ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Grifols SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose6.640
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Grifols with someone you think should read this too:
  • Are you bullish or bearish on Grifols? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Grifols? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Grifols SA ADR

I send you an email if I find something interesting about Grifols SA ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Grifols SA ADR.

Receive notifications about Grifols SA ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.